Government drug pricing policy threatening pharmaceutical industry

Published: 2008-11-19 07:00:00

Updated: 2008-11-19 07:00:00

The recent decision by the Health Insurance Review and Assessment Service (HIRA) to evaluate the cost-effectiveness of cholesterol-lowering medicines based on individual products instead of active ingredients is putting bigger pressure on local pharmaceutical firms, which have focused on cheap ge...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK